Core Insights - Ocumetics Technology Corp. is hosting a webinar to discuss one-month patient results from its initial Group 1 patients who received the Ocumetics Accommodating Intraocular Lens [1][2] - The webinar will cover updates on the first-in-human study and future steps in the development process [2][3] Company Overview - Ocumetics Technology Corp. is a Canadian research and product development company focused on advanced vision correction solutions aimed at enhancing patient quality of life [4] - The company is developing innovative intraocular lenses designed to fit within the natural lens compartment of the eye, potentially eliminating the need for corrective lenses [5] Webinar Details - The webinar is scheduled for October 15, 2025, at 6:00 PM ET, featuring CEO Dean Burns [2] - Key topics will include one-month postoperative patient results, next steps for the Ocumetics study, and a live Q&A session [6]

   Calgary, Alberta – TheNewswire - September 16, 2025 - Ocumetics Technology Corp. (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is excited to announce that it has completed one-month postoperative examinations of the first patients who were implanted with the Ocumetics Accommodating Intraocular Lens in Mexico City on August 15, 2025 (the “Ocumetics Lens”).   “On Friday September 12th, we performed one-month postoperative examinations of ...

Core Insights - Ocumetics Technology Corp. has successfully completed the one-week postoperative examination of the first patients implanted with the Ocumetics Accommodating Intraocular Lens, with all patients recovering well and no complications observed [1][3] - The company is now recruiting additional individuals to complete the first group of patients for the Ocumetics Lens [2] - The Ocumetics Lens aims to redefine vision correction by allowing the eye's natural muscular activity to focus on both distant and near objects without the need for glasses or contact lenses after cataract surgery [3][5] Company Overview - Ocumetics Technology Corp. is a Canadian research and product development company focused on advanced vision correction solutions to enhance patients' quality of life [4] - The company is dedicated to transforming the field of ophthalmology through innovative research and development of state-of-the-art intraocular lenses and other vision-enhancing technologies [4] Product Development - The Ocumetics Lens is designed to fit within the natural lens compartment of the eye, potentially eliminating the need for corrective lenses by providing clear vision at all distances [5] - The company is currently in the preclinical study phase for this groundbreaking technology in the ophthalmic industry [5]

Core Insights - Ocumetics Technology Corp. has successfully completed key clinical milestones and is preparing for first-in-human surgeries of its innovative accommodating intraocular lens [1][2] - The company has made significant clinical progress, including site initiation, ethics committee approval, and patient recruitment for the clinical study in Mexico City [4][6] Financial Activities - Ocumetics has opted not to proceed with the second tranche of a private placement due to the imminent FIH surgeries, having successfully raised $1,124,362 in the first tranche [3] - The company incurred fees of $68,610 and issued 196,029 agent's warrants to Numus Capital Corp. for assistance with the financing [3] Clinical Progress - Key milestones include the completion of clinical study protocol training, receipt of ethics committee approval, and commencement of patient recruitment [4] - The first-in-human implantation of the accommodating intraocular lens is anticipated shortly, with ongoing monitoring of patient progress [4][6] - Planning for Group 2 surgeries is expected to take place in Q1 2026 [4]

Core Insights - Ocumetics Technology Corp. has received verbal approval from the ethics committee for its first in-human study of the Ocumetics accommodating intraocular lens, with formal written approval expected by August 5, 2025 [1][2] Group 1: Clinical Study Approval - The ethics committee's approval is a significant milestone in Ocumetics' 18-year journey to innovate vision care, allowing the company to proceed with the first clinical use of the Ocumetics Lens [2] - The approved clinical study protocol includes clinical procedures, safety monitoring, inclusion and exclusion criteria, and study endpoints, ensuring compliance with international standards for patient safety and scientific integrity [2] Group 2: Collaboration and Development - The study will be conducted in collaboration with a recognized regulatory consulting group that contributed to the protocol development and submission to regulatory agencies [3] - The approval reflects the strength of the study protocol and the readiness of the clinical team, marking a major advancement in intraocular lens development [4] Group 3: Product Overview - Ocumetics has developed an innovative intraocular lens designed to fit within the natural lens compartment of the eye, potentially eliminating the need for corrective lenses [5] - The lens allows the eye's natural muscle activity to shift focus from distance to near, providing clear vision at all distances without glasses or contact lenses [5]

Core Insights - Ocumetics Technology Corp. has achieved a significant breakthrough in the development of next-generation intraocular lens technology, demonstrating accommodative power change in laboratory testing [1][2] - The company plans to prepare for first-in-human studies scheduled for summer 2025, following successful laboratory results [2][3] Company Overview - Ocumetics Technology Corp. is a Canadian research and product development company focused on advanced vision correction solutions aimed at enhancing patients' quality of life [4] - The company is dedicated to transforming the field of ophthalmology through innovative research and development of state-of-the-art intraocular lenses and other vision-enhancing technologies [4] Technological Development - The intraocular lens developed by Ocumetics is designed to fit within the natural lens compartment of the eye, potentially eliminating the need for corrective lenses [5] - This lens allows the eye's natural muscle activity to shift focus from distance to near, providing clear vision at all distances without the assistance of glasses or contact lenses [5] Research and Development - The testing utilized Ocumetics' Lens Analyzer (IOLA) bench testing platform to simulate ciliary body pressures, confirming the lens's ability to respond dynamically [2][3] - The company continues to collaborate with leading ophthalmic researchers, engineers, and clinical advisors to advance its rigorous R&D roadmap [3]